SIGA Technologies

About:

At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox.

Website: http://www.siga.com/

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Defense, Biomedical Advanced Research and Development Authority (BARDA), MacAndrews & Forbes, Incorporated

Description:

SIGA is a pharmaceutical company specializing in the development of pharmaceutical solutions for some of the most lethal pathogens – variola (smallpox), Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures.